Literature DB >> 19277429

Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities.

Maria Rita Taliani, Cecilia Becattini, Giancarlo Agnelli, Paolo Prandoni, Marco Moia, Mario Bazzan, Rosamaria Salvi, Walter Ageno, Giuliana Guazzaloca, Davide Imberti, Mauro Silingardi, Renzo Poggio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19277429

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  2 in total

1.  Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion.

Authors:  Jun Deng; Heng Mei; Wei Shi; Zhi-Qing Pang; Bo Zhang; Tao Guo; Hua-Fang Wang; Xin-Guo Jiang; Yu Hu
Journal:  Curr Med Sci       Date:  2018-06-22

Review 2.  Optimal duration of anticoagulation in patients with venous thromboembolism.

Authors:  Paolo Prandoni; Chiara Piovella; Luca Spiezia; Fabio Dalla Valle; Raffaele Pesavento
Journal:  Indian J Med Res       Date:  2011-07       Impact factor: 2.375
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.